Fulminant Guillain–Barré Syndrome in A Young Adult: Case Report
Main Article Content
Abstract
.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Willison HJ, Jacobs BC, van Doorn PA. Guillain–Barré syndrome. Lancet. 2016;388(10045):717–727. doi:10.1016/S0140-6736(16)00339-1.
II. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–482. doi:10.1038/nrneurol.2014.121.
III. Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain–Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599–612. doi:10.1016/j.vaccine.2010.06.003.
IV. Yuki N, Hartung HP. Guillain–Barré syndrome. N Engl J Med. 2012;366(24):2294–2304. doi:10.1056/NEJMra1114525.
V. van Doorn PA, Van den Bergh PYK, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain–Barré syndrome. Eur J Neurol. 2023;30(12):3646–3674. doi:10.1111/ene.16073. (Wiley Online Library)
VI. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EFM. Anticipating mechanical ventilation in Guillain–Barré syndrome. Arch Neurol. 2001;58(6):893–898. doi:10.1001/archneur.58.6.893.
VII. Hughes RAC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain–Barré syndrome. Cochrane Database Syst Rev. 2014;(9):CD002063. doi:10.1002/14651858.CD002063.pub6.
VIII. Leonhard SE, Ruts L, van Doorn PA, et al. Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain–Barré syndrome. Neurology. 2023;100(13):e1395–e1404. doi:10.1212/WNL.0000000000206878. (PubMed)